Provided by Tiger Fintech (Singapore) Pte. Ltd.

Conduit Pharmaceuticals Inc.

2.00
-0.1000-4.76%
Post-market: 2.100.0996+4.98%19:57 EDT
Volume:115.08K
Turnover:234.97K
Market Cap:4.81M
PE:-0.01
High:2.13
Open:2.10
Low:2.00
Close:2.10
Loading ...
Dec 17, 2024

Major Issues Report

Form 8-K - Current report
Dec 04, 2024

Correspondence

Form CORRESP - Correspondence
Nov 25, 2024

Major Issues Report

Form 8-K - Current report
Nov 19, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Nov 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 01, 2024

Major Issues Report

Form 8-K - Current report
Oct 31, 2024

Correspondence

Form CORRESP - Correspondence
Oct 18, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 16, 2024

Major Issues Report

Form 8-K - Current report
Oct 11, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 19, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 16, 2024

Correspondence

Form CORRESP - Correspondence
Sep 13, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Sep 06, 2024

Major Issues Report

Form 8-K - Current report
Sep 04, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933